2McGuire WP, Rowinsky EK. Paclitaxel in cancer treatment [ M ].New York, Marcel Dekker Inc, 1995:201-297. 被引量:1
3周际昌主编..实用肿瘤内科学[M].北京:人民卫生出版社,2003:818.
4Vanhoefer U, Cao S, Harstrick A, et al, Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human fumor xenografts that overrexpress the multidrug resislrance protein(MRP)[J]. Ann Oncol. 1997, 8( 12): 1221-1228. 被引量:1
5Holmes FA, Velero V, Theriault RI,, et al. Phase Ⅲ trial of taxolin metastatic breast eaneer refractory to multiple prior treatment(Abstrat) [J]. Proe Am Soe Clin Oneol, 1993, 12( 1 ) :94. 被引量:1
7Marry M, Cognetti F, Maraninchi D, et al. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metatatic breast cancer administered as first-line treatment : the M77001 study group [ J ]. J Clin Oncol, 2005,23 (19) :4265 -4274. 被引量:1
8Fossella F, Pereira JR, yon Pawel J, et al. Randomized, multinational, phase m study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non- small-ceil lung cancer: the TAX 326 study group [ J]. J Clin Oncol,2003,21 ( 16 ) :3016 - 3024. 被引量:1